CAD 50,000.00
Reported federal agreement value. An agreement can cover several years; this is not the amount paid out.
Selected because the publisher reports recipient province NL; NL Ledger has not established the work, benefit or jurisdiction from this record; source fields are available below.
This is the whole reported commitment or notice value, not the amount paid or an NL allocation.
- Recipient
- Unbound Chemicals Inc.
- Public body
- National Research Council Canada
- Agreement start
- Aug. 10, 2020
- Program
- Industrial Research Assistance Program – Contributions to Firms
- Record type
- Federal grant or contribution
Receipt
agreement 172-2020-2021-Q2-954935, amendment 1
Source location evidence
Location review incomplete.
Reported address: country: CA; province: NL; city: St. John's|St. John's; postal code: A1A 1E7.
How counted: latest of 2 rows (department reports running totals). Start: 2020-08-10; end: 2021-03-31; reported: not stated. Amount: published value.
Full source fields
- _id
- 35914362
- ref_number
- 172-2020-2021-Q2-954935
- amendment_number
- 1
- amendment_date
- 2020-12-11
- agreement_type
- C
- recipient_type
- F
- recipient_business_number
- 737287334
- recipient_legal_name
- Unbound Chemicals Inc.
- recipient_operating_name
- research_organization_name
- recipient_country
- CA
- recipient_province
- NL
- recipient_city
- St. John's|St. John's
- recipient_postal_code
- A1A 1E7
- federal_riding_name_en
- St. John's East
- federal_riding_name_fr
- St. John's-Est
- federal_riding_number
- 10006
- prog_name_en
- Industrial Research Assistance Program – Contributions to Firms
- prog_name_fr
- Programme d’aide à la recherche industrielle – Contributions aux entreprises
- prog_purpose_en
- The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
- prog_purpose_fr
- Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
- agreement_title_en
- Pharmaceutical Waste Recovery Pilot Project
- agreement_title_fr
- Projet pilote de récupération de déchets pharmaceutiques
- agreement_number
- 954935
- agreement_value
- 50000
- foreign_currency_type
- foreign_currency_value
- agreement_start_date
- 2020-08-10
- agreement_end_date
- 2021-03-31
- coverage
- IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
- description_en
- Unbound Chemicals Inc. company has developed technology to collect, sort, extract, and remarket the active pharmaceutical ingredients from unused medication. This pilot project will focus on cancer medication recovery. They will collect unused cancer medicate from clinics and patients, use the incoming stock to build and test our sorting technology, analyse and extract the ingredients, and remarket ingredients to researchers with a view to determining feasibility and viability of the solution/process.
- description_fr
- L'entreprise Unbound Chemicals Inc. a mis au point une technologie permettant de collecter, trier, extraire et remettre sur le marché les ingrédients pharmaceutiques actifs des médicaments non utilisés. Ce projet pilote sera axé sur la récupération des médicaments contre le cancer. Il permettra de récupérer les médicaments anticancéreux inutilisés auprès des cliniques et des patients, d'utiliser le stock reçu pour créer et tester notre technologie de tri, d'analyser et d'extraire les ingrédients, et de les remettre sur le marché pour les chercheurs afin de déterminer la faisabilité et la viabilité de la solution/du procédé.
- naics_identifier
- 32541
- expected_results_en
- The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
- expected_results_fr
- Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
- additional_information_en
- This agreement has been amended 1 time(s). The end date of this agreements has been modified by 31 days.
- additional_information_fr
- Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 31 jours.
- owner_org
- nrc-cnrc
- owner_org_title
- National Research Council Canada | Conseil national de recherches Canada
Spot an error? Say so in the box below, or email corrections@nlledger.ca. What to send.